First-in-Human Single and Multiple Dose of GLPG1205
Clinical trial NCT01887106 · COMPLETED
Trial details
- NCT number
- NCT01887106
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2013-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.